rs58869180

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_147127.5(EVC2):​c.1711-20T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0146 in 1,484,598 control chromosomes in the GnomAD database, including 2,202 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.069 ( 1166 hom., cov: 32)
Exomes 𝑓: 0.0085 ( 1036 hom. )

Consequence

EVC2
NM_147127.5 intron

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.87

Publications

0 publications found
Variant links:
Genes affected
EVC2 (HGNC:19747): (EvC ciliary complex subunit 2) This gene encodes a protein that functions in bone formation and skeletal development. Mutations in this gene, as well as in a neighboring gene that lies in a head-to-head configuration, cause Ellis-van Creveld syndrome, an autosomal recessive skeletal dysplasia that is also known as chondroectodermal dysplasia. Mutations in this gene also cause acrofacial dysostosis Weyers type, also referred to as Curry-Hall syndrome, a disease that combines limb and facial abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
EVC2 Gene-Disease associations (from GenCC):
  • acrofacial dysostosis, Weyers type
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
  • Ellis-van Creveld syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, Myriad Women's Health, Laboratory for Molecular Medicine

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_147127.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 4-5628754-A-C is Benign according to our data. Variant chr4-5628754-A-C is described in ClinVar as Benign. ClinVar VariationId is 262606.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.23 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_147127.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EVC2
NM_147127.5
MANE Select
c.1711-20T>G
intron
N/ANP_667338.3
EVC2
NM_001166136.2
c.1471-20T>G
intron
N/ANP_001159608.1Q86UK5-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EVC2
ENST00000344408.10
TSL:1 MANE Select
c.1711-20T>G
intron
N/AENSP00000342144.5Q86UK5-1
EVC2
ENST00000310917.6
TSL:1
c.1471-20T>G
intron
N/AENSP00000311683.2Q86UK5-2
EVC2
ENST00000475313.5
TSL:1
n.1471-20T>G
intron
N/AENSP00000431981.1A0A0C4DGE7

Frequencies

GnomAD3 genomes
AF:
0.0687
AC:
10353
AN:
150786
Hom.:
1163
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.234
Gnomad AMI
AF:
0.0330
Gnomad AMR
AF:
0.0336
Gnomad ASJ
AF:
0.00404
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00168
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.00143
Gnomad OTH
AF:
0.0479
GnomAD2 exomes
AF:
0.0186
AC:
4607
AN:
247834
AF XY:
0.0139
show subpopulations
Gnomad AFR exome
AF:
0.239
Gnomad AMR exome
AF:
0.0150
Gnomad ASJ exome
AF:
0.00499
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00144
Gnomad OTH exome
AF:
0.0142
GnomAD4 exome
AF:
0.00848
AC:
11315
AN:
1333696
Hom.:
1036
Cov.:
30
AF XY:
0.00742
AC XY:
4958
AN XY:
668028
show subpopulations
African (AFR)
AF:
0.250
AC:
7956
AN:
31794
American (AMR)
AF:
0.0171
AC:
746
AN:
43746
Ashkenazi Jewish (ASJ)
AF:
0.00486
AC:
123
AN:
25308
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37972
South Asian (SAS)
AF:
0.000908
AC:
75
AN:
82626
European-Finnish (FIN)
AF:
0.0000585
AC:
3
AN:
51272
Middle Eastern (MID)
AF:
0.0314
AC:
167
AN:
5322
European-Non Finnish (NFE)
AF:
0.00114
AC:
1137
AN:
999842
Other (OTH)
AF:
0.0199
AC:
1108
AN:
55814
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
444
887
1331
1774
2218
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
258
516
774
1032
1290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0688
AC:
10383
AN:
150902
Hom.:
1166
Cov.:
32
AF XY:
0.0666
AC XY:
4912
AN XY:
73710
show subpopulations
African (AFR)
AF:
0.234
AC:
9623
AN:
41060
American (AMR)
AF:
0.0335
AC:
505
AN:
15096
Ashkenazi Jewish (ASJ)
AF:
0.00404
AC:
14
AN:
3462
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5098
South Asian (SAS)
AF:
0.00126
AC:
6
AN:
4752
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10414
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.00143
AC:
97
AN:
67726
Other (OTH)
AF:
0.0474
AC:
99
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
405
809
1214
1618
2023
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0376
Hom.:
96
Bravo
AF:
0.0796
Asia WGS
AF:
0.0210
AC:
73
AN:
3476

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not specified (2)
-
-
1
Ellis-van Creveld syndrome;C0457013:Curry-Hall syndrome (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.022
DANN
Benign
0.53
PhyloP100
-1.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs58869180;
hg19: chr4-5630481;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.